Details for New Drug Application (NDA): 090261
✉ Email this page to a colleague
The generic ingredient in LEVETIRACETAM is levetiracetam. There are thirty-five drug master file entries for this compound. Eighty-six suppliers are listed for this compound. Additional details are available on the levetiracetam profile page.
Summary for 090261
Tradename: | LEVETIRACETAM |
Applicant: | Mylan |
Ingredient: | levetiracetam |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 090261
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 090261
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LEVETIRACETAM | levetiracetam | TABLET;ORAL | 090261 | ANDA | Mylan Pharmaceuticals Inc. | 0378-5619 | 0378-5619-91 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-5619-91) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1GM | ||||
Approval Date: | Dec 8, 2009 | TE: | AB | RLD: | No |
Complete Access Available with Subscription